Abstract
Neuromodulation has wide ranging potential applications in replacing impaired neural function (prosthetics), as a novel form of medical treatment (therapy), and as a tool for investigating neurons and neural function (research). Voltage and current controlled electrical neural stimulation (ENS) are methods that have already been widely applied in both neuroscience and clinical practice for neuroprosthetics. However, there are numerous alternative methods of stimulating or inhibiting neurons. This paper reviews the state-of-the-art in ENS as well as alternative neuromodulation techniques—presenting the operational concepts, technical implementation and limitations—in order to inform system design choices.
1. Introduction
Neuromodulation is already a multi-billion dollar industry and is expected to double in the near future (Gofeld, ). Alone has seen the launch of the European Human Brain Project and the US Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative—massive collaborative projects which look set to enhance our understanding and create myriad new opportunities in this space.
Today there are 3 main applications for neuromodulation. (1) Prosthetics—devices that replace or improve impaired sensory, motor or cognitive neural function—examples already exist in clinical use such as cochlear implants, and many more are in active development such as retinal and proprioceptive implants (Theogarajan, ; Williams and Constandinou, 2013). (2) Therapy—devices to neurally regulate the body's organs for medical benefit—possibly enabling control of insulin release for diabetics or renal salt absorption for people with hypertension (Stanslaski et al., ; Famm et al., ). It is also used for treatment of epilepsy, depression, traumatic brain injury, Parkinsons disease and obesity (Testerman et al., ). (3) Neuroscience research—investigating the function of neurons and neural networks in the peripheral and central nervous system (PNS and CNS)—enhancing or creating new applications for neuromodulation (Fenno et al., ).
All of these applications employ neuromodulation—stimulating or blocking the flow of Action Potentials (APs) through the nervous system. Electrical Neural Stimulation (ENS) has historically been the main technique for neuromodulation and has played a crucial role in neuroscience ever since Galvani first demonstrated that neurons could be electrically stimulated in the 18th century. However, recent developments in alternative modulation methods potentially offer significant advantages over ENS and could catalyze a wide expansion of neuromodulation for clinical applications.
This paper presents the current state of the art in neuromodulation methods—describing advantages, limitations, implementations and applicability. It is laid out as follows: section 2 discusses the physics of action potential creation; section 3 describes and contrasts the various methods of achieving neuromodulation; and section 4 summarizes the current state of the art.
2. Biophysics of action potential generation
Neuronal cell membranes consist mainly of a phospholipid bilayer across which selective ion pumps work to create a separation of charge, ultimately resulting in a resting cell membrane polarization where the intracellular potential is between 60 and 80 mV below the extracellular fluid and where the bilayer acts as the dielectric of a capacitor (Figure 1A).
Figure 1
Neural stimulation works by causing a depolarization of part of the cell membrane. If this depolarization reduces the transmembrane potential to a critical level (threshold), voltage gated sodium ion channels open and a positive feedback loop is created that amplifies a small depolarization (~15 mV) into a full reverse polarization of the membrane (Figure 1B) and an action potential is created. This in turn depolarizes the surrounding membrane and ultimately causes the action potential to propagate along the neuron. The states and dynamics of voltage gated sodium and potassium channels play major roles in neuromodulation. Examples of two types of transmembrane currents: depolarizing (by convention negative current, typically sodium ions, INa, or calcium ions) and hyperpolarizing (positive current, typically potassium ions, IK) are shown in Figure 1B.
When the axon is coated in a myelin sheath (as depicted in Figure 2) the exchange of ions is limited to the gaps in the sheath (the Nodes of Ranvier). This restriction causes action potential to appear to leap from node to node, whilst the myelination of the axon significantly reduces the membrane capacitance and greatly increasing the speed of the AP propagation.
Figure 2
Each neural cell represents an spatially extended electrically active object and in order to model it the cell can be considered to be divided into equipotential compartments (as shown in Figure 2). Then the change of the charge (Q) inside a compartment is given by:
where Iionic represents the currents through the ion channels and pumps into that compartment, Iintracell is the internal cell current influx from neighboring compartments, and Iinjected are externally injected currents. Replacing Q = CmU in Equation (1), it becomes a classical Hodgkin-Huxley type Equation (Hodgkin and Huxley,
Generally speaking both membrane kinetics and the channel conductance (permeability) are affected by temperature (Hodgkin and Huxley,
where Q10 is a special constant corresponding to the kinetics and permeability increase when the temperature is increased by 10°C.
Note that the model described by Equation (2) assumes that the extracellular potential that is produced by the neuron's own activity is negligible. Furthermore, it is assumed that the ionic pumps quickly restore the ionic gradients across the membrane so that the reversal potentials in Equation (3) are constant (otherwise the Goldman-Hodgkin-Katz equation should be used for the ionic currents).
3. Neuromodulation modalities
Based on Equation (2), a depolarization can be initiated in a number of ways. This section describes 6 classes of neuromodulation (including the principle of operation and current methods of implementation) and contrasts key parameters in Table 1.
Table 1
| Direct electrical | Magnetic | Opto-genetic | Thermal | Acoustic/ mechanical | Chemical | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VCSa | CCS | QCS | TMS | μMS | Optically induced | Nano-particles | Neuro-transmitter | Ion conc. | |||
| Typical stimulus power/electrode | ~100 μW | ~1 kW | 100 mW/cm2 | ~1 kW/cm2b | 100 W | ~10 mW/cm2b | ~100 μW | ~1 μW | |||
| Efficiency:VCS > QCS >CCS | |||||||||||
| AP latency | <1 ms | ~1 ms | ~10 ms c | ~1-10 ms | ~1 ms | ~10 s | ~10 ms | ~1 sd | ~1 min | ||
| Spatial resolution | Limited by electrode (e.g., size, charge capacitye, f) | ~1 cm | ~100 μm | Sub-Cellular | ~10μm | Single Cell | ~0.1–1 mm | Depends on chemical diffusions, etc. | |||
| Invasiveness | Either | Either | Yes | No | Yes | Either | Yes | Yes | No | Yes | Yes |
| Genetic preparation | No | No | No | No | No | Yes | No | Yes | No | No | No |
| Typ. system size | ~1 mm | ~10 cm | ~1 mm | ~1 cm | ~10 cm | ~10 cm | ~1 mm | ||||
| Typ. size of electrode/coil/aperture | ~100 μm | ø ~1 cm | ø ~1 mm | ~100 μm | ~100 μm | ø ~1 mm | ~1 mm | ~10 μm | |||
| Use on human | Yes | Yes | No | No | No | No | No | ||||
| (Potential) Health Risk | Electrochemical reaction | Stroke, eddy current | Not clear | Photo-toxicity/ bleaching | Thermal tissue damage | NP toxicity | Standing wave | Neuro-transmitter leakage | Electro-chemical reaction | ||
| Cellular specificity | Stimulation waveform profile | Not clear | Not Clear | Orientation | Gene-targeting | Not clear | Protein-targeting | Not clear | Neuro-transmitter level | Not clear | |
| Target nervous system | CNS/ PNS | CNS/ PNS | CNS/ PNS | CNS/ PNS | CNS/ PNS | CNS | CNS/ PNS | CNS | CNS | CNS | CNS/ PNS |
| Main/potential applications | DBS | RI, CP | ISMS | Psychiatry | Research | RI, DBS, Research | CI | Research | RI, CI | RI, CP | Facilitate ENS |
| Engineering challenges for miniaturization | Current control | Energy efficiency | Sensitive to parasitic capacitances | Large devices | High power driver | Genetic modification | High power | Toxicity | High power | Complex fabrication | |
Comparison of different neuromodulation modalities.
VCS, Voltage Controlled Stimulation; CCS, Current Controlled Stimulation; QCS, Charge Controlled Stimulation; TMS, Transcranial Magnetic Stimulation; AP, Action Potential; CNS/PNS; Central/Peripheral Nervous System; DBS, Deep Brain Stim.; RI, Retinal Implant; CI, Cochlear Implant; CP, Cortical Prostheses; ISMS, Intraspinal Microstimulation; NP, Nano particles.
Spatial-peak temporal-average intensity.
<1 ms if coil is perpendicular to the plane of the neuron; ~10 ms if parallel.
Can be improved to ms using electro-osmosis.
Minimum required charge quantity for stimulation determines the minimum surface area of the electrode as electrodes have a a maximum recommended charge capacity per unit area. Cogan (
Transcranial Direct Current Stimulation (tDCS) is a non-invasive method for stimulation and has a poor resolution.
3.1. Direct electrical
Direct electrical stimulation uses electrodes to apply a potential gradient across a neuron (e.g., differing extracellular potentials at nodes Vext,1, Vext,2, and Vext,3 in Figure 2 (return electrode is placed in a distant area), which are initially closely followed by the intracellular potentials) causing intracellular ionic current flow (Iintracell) and localized depolarization and hyperpolarization of the cell membrane (Vm1, Vm2, and Vm3 in Figure 2B) that results in neural stimulation. Applying a different potential gradient can be used to create a region of cell membrane hyperpolarization sufficient to block action potential propagation, thereby achieving neural inhibition. More complex stimulation, inhibition and selectivity mechanisms are also possible by applying waveforms that exploit the differing time constants of the ion channels—for example anode break stimulation occurs when a long hyperpolarizing (inhibitory) pulse is suddenly ceased and results from differences in the rate that the sodium activation and inactivation gates change state (Zhou and Greenbaum, 2010).
Key considerations for direct electrical stimulation are safety, energy efficiency, area, spatial resolution and programmability. Safety is largely determined by two key characteristics: (1) the electrode material biocompatibility, and (2) minimizing the net creation of harmful electrochemical products. This latter criteria is typically achieved by limiting the rate and total amount of charge delivered through the electrodes, restricting the maximum potential difference across the electrodes and minimizing the residual charge left on the electrodes following stimulation. Commercial products use large DC blocking capacitors to limit this residual charge, improving safety at the expense of size and weight (which limits the number of channels that can be implemented). As a result, designs free of blocking capacitors are an active area of research (Sit and Sarpeshkar,
The required potential gradients for stimulation can be generated using Voltage, Current or Charge controlled stimulators (see Figure 3).
Figure 3

(A) Current-Controlled Stimulation (B) Voltage-Controlled Stimulation (C) Charge-Controlled Stimulation (D) Electrode-Electrolyte Interface model [Rs is solution spreading resistance, Cdl is double layer capacitance, Rt is charge transfer resistance (Luan and Constandinou,
3.1.1. Voltage controlled
Directly applying a voltage between two electrodes is the simplest and lowest power method of direct neural stimulation, however, the lack of control of charge delivered to the electrodes leads to electrode degradation and toxic redox products. Clinically these stimulators are used in Deep Brain Stimulation (Hardesty and Sackeim,
3.1.2. Current controlled
In current controlled stimulation the current flowing between two electrodes is controlled by applying a time varying potential difference across the electrodes. Controlling current enables charge balanced waveforms to be used (e.g., by careful calibration of current sources, use of an H-bridge; or series DC blocking capacitors) and the charge delivered to the electrodes can be constrained within their charge capacity. However, controlling the current leads to significant power waste with implications for tissue damage and battery lifetime. Clinically this approach is used in cochlear implants and is the most popular method in research publications (Thurbon et al.,
Transcranial Direct Current Stimulation (tDCS) has recently been used to study the physiology of the CNS in human (Nitsche and Paulus,
3.1.3. Charge controlled
Charge controlled stimulation combines voltage stimulation with a capacitor to limit or control the charge delivered to the electrodes (Ghovanloo,
3.2. Magnetic
The mechanism for magnetic stimulation is similar to that of direct electrical stimulation, except that the potential gradients are induced in the tissue by a rapidly changing strong magnetic field (>1 T)—typically generated by discharging large capacitors through an electromagnet or via kilowatt amplifier.
It is usually implemented transcutaneously [e.g., Transcranial Magnetic Stimulation (TMS)] and hence non-invasively. The removal of the electrochemical issues associated with the electrode, potentially offers a major advantage over electrical stimulation, however, these devices currently offer poor spatial selectivity and high peak power consumption. The improvement of stimulus focality mainly relies on the redesign of the stimulation coil. Recently, Bonmassar et al. (
Hand-held TMS devices have been used for neuroscience purposes and clinically for stroke and depression treatment. However, cautions must be paid when using TMS with any metallic implant like pacemaker, where the metal sheet could be heated by the eddy current generated during TMS. Reviews on TMS can be found in Rossini et al. (
3.3. Optogenetic
Optogenetics is a relatively new neuromodulation technology in which light-sensitive proteins (“opsins”) are genetically inserted into cell membranes or cells (Nagel et al.,
Figure 4

(A) An unilluminated channelrhodopsin-2 (ChR2) ion channel and halorhodopsin (HR) ion pump are closed and inactive. (B) Once exposed to light of specific wavelength, ChR2 allows certain positive ions into the cell, and HR begins to pump chloride ions in. (C) Activation of ChR2 initiates individual action potentials, in contrast HR activation suppresses action potentials, redrawn from Boyden et al. (
However, creating a chronic, portable implant capable of exploiting even a fraction of the potential of this technique remains an open challenge (Williams and Denison, 2013). In-vivo experimental setups to date have typically involved either benchtop lasers (coupled with fiber-optics) or transcutaneous illumination. However, McCall et al. (
3.4. Thermal
Thermal modulation of neural activity is believed to result from a combination of the temperature induced changes in the transmembrane capacitance (the last term in the RHS of Equation 2) and non-uniform changes in the conductance dynamics of the various ionic channels (Equations 3, 4) (Duke et al.,
During rapid localized heating, the capacitive effect dominates and the reduced transmembrane capacitance leads to ionic current flow, depolarization and action potential initiation (Shapiro et al.,
There are a number of ways of inducing this thermal change, here we cover optical and nanoparticle stimulation. Bench-top equipment has previously been required, however, an emerging method using a CMOS lab-on-chip micro-heater array is recently reported in Reverter et al. (
3.4.1. Optically induced thermal modulation
Rapid heating can be achieved through the targeting of near infra-red laser light on a neuron or nerve (Wells et al.,
3.4.2. Microwave/RF heating of nanoparticles
Magnetic nanoparticles can absorb RF radiation and therefore heat surrounding tissue. Combining these particles with proteins known to bind to specific protein targets on neural cell membranes has been shown to enable focused heating of target cells. Although this approach could potentially give very good spatial resolution, the temporal resolution and power consumption of this technique remain poor and the safety of the nanoparticles is unclear (Huang et al.,
3.5. Acoustic/mechanical
Acoustic modulation is an emerging method. Experiments have indicated that on-off modulated ultrasound waves can elicit action potentials from retinal and brain cells (Tufail et al.,
The main benefit of this method is that it is non-invasive and is likely to offer better spatial resolution than other non-invasive techniques—particularly useful for applications like retinal prostheses (Menz et al.,
3.6. Chemical
Microfluidics can be used to control the chemical environment around a neuron, potentially changing its transmembrane or post-synaptic potential and inducing or suppressing action potential generation. Achieving high temporal or spatial resolution with such systems may be challenging—depending on concentrations required to elicit effects and the dynamics of the chemical diffusion, breakdown or uptake in the tissue. However, it is an approach that may be suited to applications requiring a longer term effect with a wider area of effect, e.g., Deep Brain Stimulation. Major challenges with this approach include safe chemical storage, modulation efficacy and economic manufacture.
3.6.1. Neurotransmitter modulation
Neurotransmitter molecules released near the synapses between two neurons, bind to the receptors in the post-synaptic cleft—altering the post-synaptic potential or initiating a chemical change that affects neuronal signal transmission. The selective sensitivity of neurons to specific neurotransmitters means that specific types of neurons can potentially be targeted even in a heterogeneous environment (like the retina) (Theogarajan,
3.6.2. Ionic concentration
Sequestration or release of anions or cations near a neuron disrupts the diffusion and potential gradients across the cell membrane and acts to modulate neural transmission. This can be used for standalone inhibition or to reduce required stimulation thresholds in tandem with another stimulation technique (Song et al.,
4. Discussion
Choosing a neuromodulation method for clinical application is guided by 3 main considerations:
The safety of a modulation method (including tissue damage, side effects and ethical considerations) are of primary importance. All the techniques discussed here have the potential to cause harm if misapplied, however, optogenetics and nanoparticle based thermal modulation stand out as facing particularly tough challenges in making the leap to human clinical use, due to genetic modification and nanoparticle concerns.
The efficacy of each modulation method for a particular application is dependent on: the required modulatory effect; the spatial, temporal and cellular resolution; and the biological characteristics of the modulation site. Precise control of action potential timing and frequency (typically desired for sensory and motor prostheses) is suited to electrical or optogenetic methods (Figure 5 shows how various methods compare in terms of spatio-temporal resolution); whereas larger scale, unfocused neural activity suppression or promotion (such as brain stimulation for tremor, depression or epilepsy) is better suited to electrical, magnetic, chemical or potentially thermal nanoparticle methods.
The suitability to a specific application use case (e.g., the frequency, duration and range of situations in which modulation will be applied) is largely dependent on requirements for acute or chronic use. Short term use in a clinical setting leads to a strong preference for a non-invasive solution such as transcranial electrical or magnetic modulation or potentially an acoustic/mechanical solution. On the other hand, long term, frequent modulation means portability is a priority and invasive solutions become more acceptable—currently favoring electrical modulation.
Figure 5

Spatio-temporal resolution of various neuromodulation methods. The open circle represents non-invasive methods and the black dots invasive methods.
There is a good reason why electrical neural stimulation is the most widely used today. It is the most mature of the stimulation technologies with low AP latency and capable of a wide range of spatial resolutions that satisfy most applications. Microelectronic fabrication can already produce stimulators that are small, implantable, low power and safe, and research is underway to improve the stimulation efficiency, efficacy and to integrate more channels onto a single chip. However, ENS is not without its limitations, and these represent an opportunity for competing methods to prosper.
This review has identified a wide diversity of available neuromodulation techniques which, although less mature, each demonstrate unique strengths and have the potential to supplant ENS in specific applications. For example, in deep brain stimulation, spread of electrical stimulus has been linked to side-effects such as depression. A lot of research has been dedicated to design a new type of electrode which can shift and confine the stimulus within a certain area, however, pursuing other neuromodulation methods that provide greater spatial resolution or cellular specificity may be an alternative solution—e.g., chemical modulation using neurotransmitter release (offering a degree of cellular specificity), or optogenetics (with high spatial resolution and cellular specificity) may one day be viable options. The shift from ENS is already well underway in non-clinical applications, where optogenetics is a frequently favored method. Nano-particle based thermal stimulation and neurotransmitter chemical stimulation are also alternatives that offer cellular specificity and may find successful niches in this area.
Looking to the future, we see a trend for multimodal neuromodulation—combining the advantages and mitigating the disadvantages of different modalities. Examples include combining current stimulation with voltage control to reduce power (Williams and Constandinou, 2013), voltage stimulation with current control (Luan and Constandinou,
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statements
Acknowledgments
This work was supported by the Wellcome Trust Institutional Strategic Support Fund, EPSRC grants EP/I000569/1 and EP/K015060/1, and EU FP7 “SeeBetter.”
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
BawaG. (2008). A Switched Capacitor based Micro-stimulator for Deep Brain Stimulation. PhD thesis, North Carolina State University, Raleigh, NC.
2
BonmassarG.LeeS. W.FreemanD. K.PolasekM.FriedS. I.GaleJ. T. (2012). Microscopic magnetic stimulation of neural tissue. Nat. Commun. 3, 921. 10.1038/ncomms1914
3
BoydenE. S.ZhangF.BambergE.NagelG.DeisserothK. (2005). Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8, 1263–1268. 10.1038/nn1525
4
BusskampV.RoskaB. (2011). Optogenetic approaches to restoring visual function in retinitis pigmentosa. Curr. Opin. Neurobiol. 21, 1–5. 10.1016/j.conb.2011.06.001
5
ChowB. Y.HanX.DobryA. S.QianX.ChuongA. S.LiM.et al. (2010). High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature463, 98–102. 10.1038/nature08652
6
CoganS. F. (2008). Neural stimulation and recording electrodes. Ann. Rev. Biomed. Eng. 10, 275–309. 10.1146/annurev.bioeng.10.061807.160518
7
DayanE.CensorN.BuchE. R.SandriniM.CohenL. G. (2013). Noninvasive brain stimulation: from physiology to network dynamics and back. Nat. Neurosci. 16, 838–844. 10.1038/nn.3422
8
DeisserothK. (2011). Optogenetics. Nature8, 26–29. 10.1038/nmeth.f.324
9
DukeA. R.JenkinsM. W.LuH.McManusJ. M.ChielH. J.JansenE. D. (2013). Transient and selective suppression of neural activity with infrared light. Sci. Rep. 3:2600. 10.1038/srep02600
10
DukeA. R.PetersonE.MackanosM. A.AtkinsonJ.TylerD.JansenE. D. (2012). Hybrid electro-optical stimulation of the rat sciatic nerve induces force generation in the plantarflexor muscles. J. Neural Eng. 9:066006. 10.1088/1741-2560/9/6/066006
11
FammK.LittB.TraceyK. J.BoydenE. S.SlaouiM. (2013). Drug discovery: a jump-start for electroceuticals. Nature496, 159–161. 10.1038/496159a
12
FennoL.YizharO.DeisserothK. (2011). The development and application of optogenetics. Ann. Rev. Neurosci. 34, 389–412. 10.1146/annurev-neuro-061010-113817
13
GhovanlooM. (2006). Switched-capacitor based implantable low-power wireless microstimulating systems, in Proc. IEEE ISCAS (Kos), 4.
14
GofeldM. (2014). New horizons in neuromodulation. Curr. Pain Headache Rep. 18:397. 10.1007/s11916-013-0397-9
15
HardestyD. E.SackeimH. A. (2007). Deep brain stimulation in movement and psychiatric disorders. Biol. Psychiatry61, 831–835. 10.1016/j.biopsych.2006.08.028
16
HodgkinA.HuxleyA. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500–544.
17
HorvathJ. C.CarterO.ForteJ. D. (2014). Transcranial direct current stimulation: five important issues we aren't discussing (but probably should be). Front. Syst. Neurosci. 8:2. 10.3389/fnsys.2014.00002
18
HuangH.DelikanliS.ZengH.FerkeyD. M.PralleA. (2010). Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. Nat. Nanotechnol. 5, 602–606. 10.1038/nnano.2010.125
19
HuxleyA. F. (1959). Ion movements during nerve activity. Ann. N.Y. Acad. Sci. 81:221–246.
20
LiuX.DemosthenousA.DonaldsonN. (2008). An integrated implantable stimulator that is fail-safe without off-chip blocking-capactitors. Biomed. Circ. Syst. IEEE Trans. 2, 231–244. 10.1109/TBCAS.2008.2003199
21
LuanS.ConstandinouT. G. (2012). A novel charge-metering method for voltage mode neural stimulation, in Proc. IEEE ISCAS (Seoul), 2239–2242.
22
MachereyO.van WieringenA.CarlyonR. P.DeeksJ. M.WoutersJ. (2006). Asymmetric pulses in cochlear implants: effects of pulse shape, polarity, and rate. J. Assoc. Res. Otolaryngol. 7, 253–266. 10.1007/s10162-006-0040-0
23
McCallJ. G.KimT.-I.ShinG.HuangX.JungY. H.Al-HasaniR.et al. (2013). Fabrication and application of flexible, multimodal light-emitting devices for wireless optogenetics. Nat. Protoc. 8, 2413–2428. 10.1038/nprot.2013.158
24
MenzM. D.OralkanO.Khuri-YakubP. T.BaccusS. A. (2013). Precise neural stimulation in the retina using focused ultrasound. J. Neurosci. 33, 4550–4560. 10.1523/JNEUROSCI.3521-12.2013
25
MouZ.TriantisI. F.WoodsV. M.ToumazouC.NikolicK. (2012). A simulation study of the combined thermoelectric extracellular stimulation of the sciatic nerve of the xenopus laevis: the localized transient heat block. IEEE Trans. Biomed. Eng. 59, 1758–1769. 10.1109/TBME.2012.2194146
26
NagelG.SzellasT.HuhnW.KateriyaS.AdeishviliN.BertholdP.et al. (2003). Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc. Natl. Acad. Sci. U.S.A. 100, 13940–13945. 10.1073/pnas.1936192100
27
NaorO.HertzbergY.ZemelE.KimmelE.ShohamS. (2012). Towards multifocal ultrasonic neural stimulation ii: design considerations for an acoustic retinal prosthesis. J. Neural Eng. 9:026006. 10.1088/1741-2560/9/2/026006
28
NitscheM. A.PaulusW. (2000). Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J. Physiol. 527(Pt 3), 633–639. 10.1111/j.1469-7793.2000.t01-1-00633.x
29
PetersonE. J.TylerD. J. (2014). Motor neuron activation in peripheral nerves using infrared neural stimulation. J. Neural Eng. 11:016001. 10.1088/1741-2560/11/1/016001
30
ReverterF.LiuY.ProdromakisT.NikolicK.GeorgiouP.ConstandinouT. (2014). Design considerations for a cmos lab-on-chip microheater array to facilitate the in-vitro thermal stimulation of neurons, in Proc. IEEE ISCAS (Melbourne, VIC).
31
RichterC.-P.MaticA. I.WellsJ. D.JansenE. D.WalshJ. T. (2011). Neural stimulation with optical radiation. Laser Photon. Rev. 5, 68–80. 10.1002/lpor.200900044
32
RoselliniW. M.YooP. B.EngineerN.ArmstrongS.WeinerR. L.BurressC.et al. (2011). A voltage-controlled capacitive discharge method for electrical activation of peripheral nerves. Neuromodulation14, 493–499. discussion: 500. 10.1111/j.1525-1403.2011.00398.x
33
RossiniP.RosinniL.FerreriF. (2010). Brain-behavior relations: transcranial magnetic stimulation: a review. IEEE Eng. Med. Biol. Mag. 29, 84–96. 10.1109/MEMB.2009.935474
34
ShapiroM. G.HommaK.VillarrealS.RichterC.-P.BezanillaF. (2012). Infrared light excites cells by changing their electrical capacitance. Nat. Commun. 3, 736. 10.1038/ncomms1742
35
SitJ.-J.SarpeshkarR. (2007). A low-power blocking-capacitor-free charge-balanced electrode-stimulator chip with less than 6 na dc error for 1-ma full-scale stimulation. IEEE Trans. Biomed. Circ. Syst. 1, 172–183. 10.1109/TBCAS.2007.911631
36
SongY.-A.MelikR.RabieA. N.IbrahimA. M. S.MosesD.TanA.et al. (2011). Electrochemical activation and inhibition of neuromuscular systems through modulation of ion concentrations with ion-selective membranes. Nat. Mater. 10, 980–986. 10.1038/nmat3146
37
SrinivasanA. G.LandsbergerD. M.ShannonR. V. (2010). Current focusing sharpens local peaks of excitation in cochlear implant stimulation. Hear. Res. 270, 89–100. 10.1016/j.heares.2010.09.004
38
StanslaskiS.AfsharP.CongP.GiftakisJ.StypulkowskiP.CarlsonD.et al. (2012). Design and validation of a fully implantable, chronic, closed-loop neuromodulation device with concurrent sensing and stimulation. IEEE Trans. Neural Syst. Rehabil. Eng. 20, 410–421. 10.1109/TNSRE.2012.2183617
39
TestermanR. L.RiseM. T.StypulkowskiP. H. (2006). Electrical stimulation as therapy for neurological disorder. IEEE Eng. Med. Biol. Mag. 25, 74–78. 10.1109/MEMB.2006.1705750
40
TheogarajanL. (2012). Strategies for restoring vision to the blind: current and emerging technologies. Neurosci. Lett. 519, 129–133. 10.1016/j.neulet.2012.02.001
41
ThurbonD.LÃijscherH. R.HofstetterT.RedmanS. J. (1998). Passive electrical properties of ventral horn neurons in rat spinal cord slices. J. Neurophysiol. 80, 2485–2502.
42
TufailY.MatyushovA.BaldwinN.TauchmannM. L.GeorgesJ.YoshihiroA.et al. (2010). Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron66, 681–694. 10.1016/j.neuron.2010.05.008
43
WellsJ.KaoC.JansenE. D.KonradP.Mahadevan-JansenA. (2005). Application of infrared light for in vivo neural stimulation. J. Biomed. Opt. 10:064003. 10.1117/1.2121772
44
WellsJ.KaoC.KonradP.MilnerT.KimJ.Mahadevan-JansenA.et al. (2007). Biophysical mechanisms of transient optical stimulation of peripheral nerve. Biophys. J. 93, 2567–2580. 10.1529/biophysj.107.104786
45
WilliamsI.ConstandinouT. G. (2013). An energy-efficient, dynamic voltage scaling neural stimulator for a proprioceptive prosthesis. Biomed. Circ. Syst. IEEE Trans. 7, 129–139. 10.1109/TBCAS.2013.2256906
46
WilliamsJ. C.DenisonT. (2013). From optogenetic technologies to neuromodulation therapies. Sci. Transl. Med. 5, 177ps6. 10.1126/scitranslmed.3003100
47
WongL.HossainS.TaA.EdvinssonJ.RivasD.NaasH. (2004). A very low-power cmos mixed-signal ic for implantable pacemaker applications. IEEE J. Solid-State Circ. 39, 2446–2456. 10.1109/JSSC.2004.837027
48
WongsarnpigoonA.GrillW. M. (2010). Energy-efficient waveform shapes for neural stimulation revealed with a genetic algorithm. J. Neural Eng. 7:046009. 10.1088/1741-2560/7/4/046009
49
YizharO.FennoL. E.DavidsonT. J.MogriM.DeisserothK. (2011). Optogenetics in neural systems. Neuron71, 9–34. 10.1016/j.neuron.2011.06.004
50
ZhouD.GreenbaumE. (2010). Implantable Neural Prostheses 2: Techniques and Engineering Approaches. Biological and Medical Physics, Biomedical Engineering, Springer. 10.1007/978-0-387-98120-8
Summary
Keywords
neuromodulation, neural modulation, neurostimulation, neural stimulation, neuroprosthetics, neural prosthesis
Citation
Luan S, Williams I, Nikolic K and Constandinou TG (2014) Neuromodulation: present and emerging methods. Front. Neuroeng. 7:27. doi: 10.3389/fneng.2014.00027
Received
05 March 2014
Accepted
24 June 2014
Published
15 July 2014
Volume
7 - 2014
Edited by
Martin Stelzle, University of Tübingen, Germany
Reviewed by
Ulrich Egert, Univ. Freiburg, Germany; Xavier Navarro, Universitat Autonoma de Barcelona, Spain; Alfred Stett, Natural and Medical Sciences Institute, Germany; Robert J. Greenberg, Second Sight Medical Products, Inc., USA
Copyright
© 2014 Luan, Williams, Nikolic and Constandinou.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Song Luan, Imperial College London, B422 Bessemer Building, SW7 2AZ London, UK e-mail: song.luan09@imperial.ac.uk
This article was submitted to the journal Frontiers in Neuroengineering.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.